Skip to main content

Peer Review reports

From: Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Original Submission
13 Oct 2020 Submitted Original manuscript
20 Oct 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
22 Oct 2020 Editorially accepted
2 Nov 2020 Article published 10.1186/s13063-020-04839-5

You can find further information about peer review here.

Back to article page